drugset / Trial / NCT07575932

A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)

NCT07575932

Phase 2 Recruiting 872 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is being done to learn about the safety and effects of the study drugs, PF-08653945 and PF-08653944, when given alone or together for weight loss, compared to a placebo (a dummy drug that has no active ingredient in it).

Timeline

Start
2026-05-11
Primary completion
2027-08-04
Completion
2028-01-05

Drugs

EvaluationDrugModalityDoseRoute
Subject MET097 Peptide Subcutaneous
Subject PF-08653945 Unknown Subcutaneous